Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Adjuvant Chemotherapy
- Biliary Tract Cancer
- Capecitabine
- Cholangiocarcinoma
- Cisplatin
- Gemcitabine
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 19 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03079427
- Collaborators
- Bundang CHA Hospital
- Seoul St. Mary's Hospital
- Severance Hospital
- Investigators
- Principal Investigator: Baek-Yeol Ryoo, MD Asan Medical Center
Get Well Soon